May 24 (Reuters)-
Immuno Biological Laboratories Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 603 mln 531 mln
(+13.5 pct) (+6.4 pct)
Operating loss 102 mln loss 216 mln
Recurring loss 69 mln loss 196 mln
Net loss 123 mln loss 219 mln
EPS loss 13.27 yen loss 23.52 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T